https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-02-01 / Leuk. Lymphoma 2007 Feb;48(2):302-10
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-02-01 / Leuk. Lymphoma 2007 Feb;48(2):302-102007-02-01 00:00:002019-02-15 08:48:42Generation of functional dendritic cells (DC) in adult acute lymphoblastic leukemia: rationale for a DC-based vaccination program for patients in complete hematological remission
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / J Clin Apher 2006 Dec;21(4):233-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / J Clin Apher 2006 Dec;21(4):233-402006-12-01 00:00:002019-02-15 08:32:37Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-01 / Exp. Hematol. 2006 Oct;34(10):1403-12
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-01 / Exp. Hematol. 2006 Oct;34(10):1403-122006-10-01 00:00:002019-02-15 08:32:38Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-07-13 / Immunobiology 2006;211(6-8):677-85
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-07-13 / Immunobiology 2006;211(6-8):677-852006-07-13 00:00:002019-02-15 08:32:39Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / Expert Rev Vaccines 2006 Apr;5(2):211-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / Expert Rev Vaccines 2006 Apr;5(2):211-222006-04-01 00:00:002019-02-15 08:32:40Current progress in the development of a cell-based vaccine for the immunotherapy of acute myeloid leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / Int. J. Oncol. 2006 Apr;28(4):855-61
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / Int. J. Oncol. 2006 Apr;28(4):855-612006-04-01 00:00:002019-02-15 08:32:40Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-04-01 / Hematology 2003 Apr;8(2):97-104
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-04-01 / Hematology 2003 Apr;8(2):97-1042003-04-01 00:00:002019-02-15 08:32:45Dendritic cell-based immunotherapy for the treatment of hematological malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1987-08-15 / Cancer Res. 1987 Aug;47(16):4335-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1987-08-15 / Cancer Res. 1987 Aug;47(16):4335-71987-08-15 00:00:002019-02-15 08:32:41Hyperthermic enhancement of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) cytotoxicity in human leukemia cells in vitro
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1984-09-01 / J. Clin. Oncol. 1984 Sep;2(9):1050-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1984-09-01 / J. Clin. Oncol. 1984 Sep;2(9):1050-61984-09-01 00:00:002019-02-15 08:32:42A proposal for the addition of hyperthermia to treatment regimens for acute and chronic leukemia
